← Evidence map

ArticleCancer cell & microenvironment

Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy.

Anna R Kwilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

82 papers cite itlatest 60 shown

2017
2019
2020
2021
2022
2023
2024
2025
2026
pooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 26005708